Thoden James B, Henderson Jenny M, Fridovich-Keil Judith L, Holden Hazel M
Department of Biochemistry, University of Wisconsin, Madison, WI 53706-1544, USA.
J Biol Chem. 2002 Jul 26;277(30):27528-34. doi: 10.1074/jbc.M204413200. Epub 2002 May 17.
UDP-galactose 4-epimerase catalyzes the interconversion of UDP-Gal and UDP-Glc during normal galactose metabolism. The mammalian form of the enzyme, unlike its Escherichia coli counterpart, can also interconvert UDP-GalNAc and UDP-GlcNAc. One key feature of the epimerase reaction mechanism is the rotation of a 4-ketopyranose intermediate in the active site. By comparing the high resolution x-ray structures of both the bacterial and human forms of the enzyme, it was previously postulated that the additional activity in the human epimerase was due to replacement of the structural equivalent of Tyr-299 in the E. coli enzyme with a cysteine residue, thereby leading to a larger active site volume. To test this hypothesis, the Y299C mutant form of the E. coli enzyme was prepared and its three-dimensional structure solved as described here. Additionally, the Y299C mutant protein was assayed for activity against both UDP-Gal and UDP-GalNAc. These studies have revealed that, indeed, this simple mutation did confer UDP-GalNAc/UDP-GlcNAc converting activity to the bacterial enzyme with minimal changes in its three-dimensional structure. Specifically, although the Y299C mutation in the bacterial enzyme resulted in a loss of epimerase activity with regard to UDP-Gal by almost 5-fold, it resulted in a gain of activity against UDP-GalNAc by more than 230-fold.
UDP-半乳糖4-差向异构酶在正常半乳糖代谢过程中催化UDP-半乳糖(UDP-Gal)和UDP-葡萄糖(UDP-Glc)的相互转化。与大肠杆菌中的该酶不同,哺乳动物形式的这种酶还能催化UDP- N -乙酰半乳糖胺(UDP-GalNAc)和UDP- N -乙酰葡萄糖胺(UDP-GlcNAc)的相互转化。差向异构酶反应机制的一个关键特征是活性位点中4-酮吡喃糖中间体的旋转。通过比较该酶细菌形式和人类形式的高分辨率X射线结构,之前推测人类差向异构酶的额外活性是由于大肠杆菌酶中与Tyr-299结构等效的位置被一个半胱氨酸残基取代,从而导致活性位点体积更大。为了验证这一假设,制备了大肠杆菌酶的Y299C突变体形式,并按此处所述解析了其三维结构。此外,还检测了Y299C突变蛋白对UDP-Gal和UDP-GalNAc的活性。这些研究表明,实际上,这个简单的突变确实赋予了细菌酶UDP-GalNAc/UDP-GlcNAc转化活性,且其三维结构变化极小。具体而言,尽管细菌酶中的Y299C突变导致其对UDP-Gal的差向异构酶活性丧失了近5倍,但对UDP-GalNAc的活性却增加了230多倍。